# Yesway, Inc.: financial statements, quarterly

YSWY · Nasdaq · CIK 1859836 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/yswy.md) · [Financials](/companies/yswy/financials.md) · [Filings](/companies/yswy/filings.md) · [Insiders](/companies/yswy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/yswy/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [678](/filings/0001104659-26-095497.md) | not reported | [921](/filings/0001104659-26-095497.md) |
| Operating income | $m | not reported | [36.7](/filings/0001104659-26-095497.md) | not reported | [47.7](/filings/0001104659-26-095497.md) |
| Income tax | $m | not reported | [0.2](/filings/0001104659-26-095497.md) | [0.0](/filings/0001104659-26-069252.md) | [6.2](/filings/0001104659-26-095497.md) |
| Net income | $m | [(0.0)](/filings/0001104659-26-069252.md) | [24.2](/filings/0001104659-26-095497.md) | [(0.0)](/filings/0001104659-26-069252.md) | [16.3](/filings/0001104659-26-095497.md) |
| Diluted EPS | $ per share | [(2.82)](/filings/0001104659-26-069252.md) | not reported | [(475.46)](/filings/0001104659-26-069252.md) | not reported |
| Basic EPS | $ per share | [(2.82)](/filings/0001104659-26-069252.md) | not reported | [(475.46)](/filings/0001104659-26-069252.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [36.6](/filings/0001104659-26-095497.md) | [0.0](/filings/0001104659-26-069252.md) | [81.6](/filings/0001104659-26-095497.md) |
| Current assets | $m | not reported | not reported | [164](/filings/0001104659-26-095497.md) | not reported | [233](/filings/0001104659-26-095497.md) |
| Total assets | $m | not reported | not reported | [1,949](/filings/0001104659-26-095497.md) | [0.0](/filings/0001104659-26-069252.md) | [2,066](/filings/0001104659-26-095497.md) |
| Current liabilities | $m | not reported | not reported | [134](/filings/0001104659-26-095497.md) | not reported | [157](/filings/0001104659-26-095497.md) |
| Total liabilities | $m | not reported | not reported | [1,126](/filings/0001104659-26-095497.md) | not reported | [1,212](/filings/0001104659-26-095497.md) |
| Long-term debt | $m | not reported | not reported | [428](/filings/0001104659-26-095497.md) | not reported | [388](/filings/0001104659-26-095497.md) |
| Current portion of debt | $m | not reported | not reported | [4.1](/filings/0001104659-26-095497.md) | not reported | [4.1](/filings/0001104659-26-095497.md) |
| Shareholders' equity | $m | [0.0](/filings/0001104659-26-069252.md) | [0.0](/filings/0001104659-26-069252.md) | [582](/filings/0001104659-26-095497.md) | [0.0](/filings/0001104659-26-069252.md) | [394](/filings/0001104659-26-095497.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.0)](/filings/0001104659-26-069252.md) | [49.2 d](/filings/0001104659-26-095497.md) | [(0.0)](/filings/0001104659-26-069252.md) | [105 d](/filings/0001104659-26-095497.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2025-03-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | units of shares | [100](/filings/0001104659-26-069252.md) | [100](/filings/0001104659-26-069252.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.